Breaking News Instant updates and real-time market news.

FISV

Fiserv

$77.83

3.23 (4.33%)

, FDC

First Data

$22.94

0.99 (4.51%)

09:01
01/22/19
01/22
09:01
01/22/19
09:01

William Blair upgrades Fiserv to Outperform on 'compelling' deal accretion

William Blair analyst Chris Shutler upgraded Fiserv (FISV) to Outperform from Market Perform saying he sees "compelling" accretion from the company's acquisition of First Data (FDC). First Data has been investing to drive growth, the revenue synergies "make sense," and Fiserv's pro forma valuation provides an attractive risk/reward profile, Shutler tells investors in a research note. Fiserv, on a pro forma basis, has another 1.5 to 2 multiple points to gain just to catch up to FIS (FIS), which would equate to around 18% to 25% stock price appreciation, adds the analyst.

FISV

Fiserv

$77.83

3.23 (4.33%)

FDC

First Data

$22.94

0.99 (4.51%)

FIS

FIS

$105.84

1.69 (1.62%)

  • 12

    Feb

  • 03

    Mar

FISV Fiserv
$77.83

3.23 (4.33%)

01/22/19
LEHM
01/22/19
DOWNGRADE
Target $23
LEHM
Equal Weight
First Data downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Ramsey El-Assal downgraded First Data (FDC) to Equal Weight saying the likelihood of a second takeover bidder is unlikely. The analyst lowered his price target for the shares to $23 from $24 to reflect the buyout price by Fiserv (FISV). He believes Fiserv should see long-term growth acceleration as First Data business investment is stepped up.
01/22/19
WBLR
01/22/19
UPGRADE
WBLR
Outperform
Fiserv upgraded to Outperform from Market Perform at William Blair
William Blair analyst Chris Shutler upgraded Fiserv (FISV) to Outperform saying he sees "compelling" accretion from the company's acquisition of First Data (FDC).
01/18/19
OPCO
01/18/19
UPGRADE
Target $88
OPCO
Outperform
Fiserv upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Glenn Greene upgraded Fiserv (FISV) to Outperform with an $88 price target. The analyst cites deal synergies from the First Data (FDC) acquisition and an attractive financial profile for the upgrade.
01/17/19
CHLM
01/17/19
NO CHANGE
Target $27
CHLM
Buy
First Data price target lowered to $27 from $35 at Craig-Hallum
Craig-Hallum analyst Brad Berning lowered his price target for First Data (FDC) to $27 from $35 after the company agreed to be acquired by Fiserv (FISV). The analyst believes the acquisition makes "a ton of strategic sense," and thinks the combined value of Fiserv and First Data translates to a $23 current fair value for First Data shares and $27 a year from now. He reiterates a Buy rating on First Data's stock.
FDC First Data
$22.94

0.99 (4.51%)

01/22/19
BUCK
01/22/19
DOWNGRADE
BUCK
Neutral
First Data downgraded to Neutral from Buy at Buckingham
First Data (FDC) is being acquired by Fiserve (FISV) for $22.74 per share in an all-stock deal valued at $22B.
FIS FIS
$105.84

1.69 (1.62%)

12/11/18
GSCO
12/11/18
UPGRADE
Target $128
GSCO
Buy
FIS upgraded to Buy at Goldman Sachs on improved revenue and margin profile
As reported earlier, Goldman Sachs analyst James Schneider upgraded FIS to Buy and raised his price target for the shares to $128 from $108 as part of his broader sector research note titled Payments & IT Services 2019 Outlook. The analyst sees the company benefiting from its defensive position given that the large portion of its revenues are "tied to mission-critical bank operations." Schneider also believes that investors are "under-appreciating" the gross margin and revenue "quality" improvements made by the management of FIS as it divests the company's non-core businesses to streamline its mix.
12/11/18
GSCO
12/11/18
UPGRADE
Target $128
GSCO
Buy
FIS upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst James Schneider upgraded FIS to Buy and raised his price target for the shares to $128 from $108. The analyst restacked his ratings in the Payments & IT Services sector to reflect a more defensive posture.
12/05/18
SPHN
12/05/18
NO CHANGE
Target $118
SPHN
Overweight
Stephens says FIS remains undervalued after headquarter visit
After a visit to the company's headquarters, Stephens analyst Brett Huff continues to view FIS as undervalued. The analyst expects the stock to "grind higher" as revenue growth accelerates in 2019 along with good margin expansion. He keeps an Overweight rating on the stock with a $118 price target.
11/14/18
LEHM
11/14/18
INITIATION
LEHM
Overweight
Barclays initiates coverage of U.S. payment processors with PayPal as top pick
As noted earlier, Barclays analyst Ramsey El-Assal initiated a group of 20 U.S. companies in the Payments, Processing, and related IT Services sector with Overweight-rated PayPal (PYPL) as his Top Pick. The analyst cites the company's "100% exposure to high-growth digital channels" along with its "clean balance sheet substantial cash position" that bring it a "strategic opportunity. El-Assal is also particularly positive on Overweight-rated WorldPay (WP) based on its strong growth potential from its exposure to "tech-enabled channels" and merger synergies, FirstData (FDC) based on the accelerating growth of its merchant channels, and Square (SQ)," whose Subscription & Services segment is blurring the lines between Payments and software". The analyst contends that the extent of being "tech-enabled" is a key differentiator in the Payments industry, assigning an Overweight rating to Alliance Data Systems (ADS), ADP (ADP), Cardtronics (CATM), Fidelity National (FIS), First Data (FDC), Fiserv (FISV), Fleetcor Technologies (FLT), Global Payments (GPN), Green Dot (GDOT), Mastercard (MA), Total System Services (TSS), Visa (V), and WEX Inc (WEX). El-Assal assigns Equal-weight ratings to EVO Payments (EVOP) and Paychex (PAYX), stating that while the companies are "solid performers" in the space, their valuation is seen as more balanced. The analyst rates MoneyGram (MGI) and Western Union (WU) at Underweight, saying that the former will struggle to re-ignite positive growth as the costs associated with regulatory scrutiny weigh on its profits and the latter will be challenged by "periodic pricing pressure eroding margins over a long period of time."

TODAY'S FREE FLY STORIES

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated  »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated  »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated  »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro CEO Rami Elghandour steps down, D. Keith Grossman to succeed »

Nevro announced that D.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

ENDP

Endo

$8.78

0.19 (2.21%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Endo initiated  »

Endo initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Hot Stocks
Ramaco Resources sees FY19 production of 2.0M tons of met coal »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

COST

Costco

$237.05

0.43 (0.18%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Costco initiated  »

Costco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 30

    May

TRN

Trinity Industries

$22.46

-0.25 (-1.10%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Conference/Events
Trinity Industries management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

COLL

Collegium Pharmaceutical

$17.35

-0.25 (-1.42%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Collegium Pharmaceutical initiated  »

Collegium Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:37
03/19/19
03/19
16:37
03/19/19
16:37
Hot Stocks
Fulton Financial raises quarterly dividend 1c to 13c per share »

Fulton Financial said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:36
03/19/19
03/19
16:36
03/19/19
16:36
Earnings
Ramaco Resources reports Q4 EPS 8c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

BDSI

BioDelivery Sciences

$4.94

0.03 (0.61%)

16:35
03/19/19
03/19
16:35
03/19/19
16:35
Initiation
BioDelivery Sciences initiated  »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

AMAG

Amag Pharmaceuticals

$12.46

0.01 (0.08%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 23

    Mar

GCP

GCP Applied Technologies

$29.95

-0.475 (-1.56%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Hot Stocks
GCP Applied Technologies names James Thompson VP, General Counsel and Secretary »

GCP Applied Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

KGJI

Kingold Jewelry

$0.89

0.0898 (11.22%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Hot Stocks
Kingold Jewelry to file extension for Form 10-K »

Kingold Jewelry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$26.29

1.745 (7.11%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Initiation
Bausch Health initiated  »

Bausch Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$18.65

-0.48 (-2.51%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Earnings
Tencent Music reports Q4 EPS 8c, consensus 8c »

Reports Q4 revenue $785M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

AMRX

Amneal Pharmaceuticals

$14.41

0.07 (0.49%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Initiation
Amneal Pharmaceuticals initiated  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

TTGT

TechTarget

$16.86

-0.07 (-0.41%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
TechTarget CEO Cotoia sells over $134K in company shares »

TechTarget CEO Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 28

    May

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
Fulton Financial authorizes up to $100M share repurchase »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.